Stammdaten
Unternehmen & Branche
| Name | Aptose Biosciences Inc. |
|---|---|
| Ticker | APTOF |
| CIK | 0000882361 |
| Boerse | US |
| SIC | 2836 · Biological Products, (No Diagnostic Substances) |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | -25,468,000 | -10.41 | 10,012,000 | -27,167,000 | |
| 2025-09-30 | 10-Q | -5,123,000 | -2.01 | 6,341,000 | -19,450,000 | |
| 2025-06-30 | 10-Q | -7,043,000 | -2.76 | 5,591,000 | -14,371,000 | |
| 2025-03-31 | 10-Q | -5,543,000 | -2.61 | 7,467,000 | -7,393,000 | |
| 2024-12-31 | 10-K | -25,430,000 | -36.38 | 10,127,000 | -4,543,000 | |
| 2024-09-30 | 10-Q | -6,953,000 | -11.33 | 10,929,000 | -9,134,000 | |
| 2024-06-30 | 10-Q | -7,252,000 | -12.99 | 10,949,000 | -2,176,000 | |
| 2024-03-31 | 10-Q | -9,640,000 | -22.02 | 12,796,000 | 137,000 | |
| 2023-12-31 | 10-K | -11,955,000 | -1.57 | 12,989,000 | -2,901,000 | |
| 2023-09-30 | 10-Q | -11,447,000 | -1.76 | 20,876,000 | 7,776,000 | |
| 2023-09-30 | 10-K | -11,447,000 | -1.76 | |||
| 2023-06-30 | 10-K | -14,129,000 | -2.27 | |||
| 2023-06-30 | 10-Q | -14,129,000 | -2.27 | 26,575,000 | 13,786,000 | |
| 2023-03-31 | 10-Q | -13,676,000 | -2.22 | 39,330,000 | 25,993,000 | |
| 2023-03-31 | 10-K | -13,676,000 | -2.25 | |||
| 2022-12-31 | 10-K | -10,000,000 | -1.67 | 51,027,000 | 37,741,000 | |
| 2022-09-30 | 10-K | -9,777,000 | -1.66 | |||
| 2022-09-30 | 10-Q | -9,777,000 | -1.59 | 57,048,000 | 46,814,000 | |
| 2022-06-30 | 10-Q | -10,565,000 | -1.72 | 64,805,000 | 55,490,000 | |
| 2022-06-30 | 10-K | -10,565,000 | -1.66 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.